{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:12:35Z","timestamp":1762506755712,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T00:00:00Z","timestamp":1457049600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00535-016-1187-z","type":"journal-article","created":{"date-parts":[[2016,3,4]],"date-time":"2016-03-04T13:54:30Z","timestamp":1457099670000},"page":"1081-1089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical characteristics and molecular analysis of hepatitis B virus reactivation in hepatitis B surface antigen-negative patients during or after immunosuppressive or cytotoxic chemotherapy"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7919-6071","authenticated-orcid":false,"given":"Kazuhiko","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoji","family":"Ishizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teiji","family":"Kuzuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Tachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Katano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kumada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidemi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,4]]},"reference":[{"key":"1187_CR1","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","volume":"2","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis. 2002;2:395\u2013403.","journal-title":"Lancet Infect Dis."},{"issue":"30","key":"1187_CR2","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","volume":"9","author":"JJ Ott","year":"2012","unstructured":"Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;9(30):2212\u20139.","journal-title":"Vaccine."},{"key":"1187_CR3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jfma.2015.06.003","volume":"114","author":"CL Lin","year":"2015","unstructured":"Lin CL, Kao JH. Perspectives and control of hepatitis B virus infection in Taiwan. J Formos Med Assoc. 2015;114:901\u20139.","journal-title":"J Formos Med Assoc"},{"key":"1187_CR4","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra031087","volume":"350","author":"D Ganem","year":"2004","unstructured":"Ganem D, Prince AM. Hepatitis B virus infection\u2013natural history and clinical consequences. N Engl J Med. 2004;350:1118\u201311129.","journal-title":"N Engl J Med"},{"key":"1187_CR5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0016-5085(75)80054-0","volume":"68","author":"JR Wands","year":"1975","unstructured":"Wands JR, Chura CM, Roll FJ, Maddrey WC. Serial studies of hepatitis associated antigen and antibody in patients receiving antitumor chemotherapy for myeloproliferative and lymphoproliferative disorders. Gastroenterology. 1975;68:105\u201312.","journal-title":"Gastroenterology"},{"key":"1187_CR6","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(75)90897-1","volume":"2","author":"RM Galbraith","year":"1975","unstructured":"Galbraith RM, Eddleston AL, Williams R, Zuckerman AJ. Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy. Lancet. 1975;2:528\u201330.","journal-title":"Lancet"},{"key":"1187_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s12072-011-9279-6","volume":"7","author":"CJ Liu","year":"2013","unstructured":"Liu CJ, Chen PJ, Chen DS, et al. Hepatitis B virus reactivation post-cancer chemotherapy: pathogenesis and management. Hepatol Int. 2013;7:316\u201326.","journal-title":"Hepatol Int"},{"key":"1187_CR8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","volume":"344","author":"I Dervite","year":"2001","unstructured":"Dervite I, Hober D, Morel P. Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab. N Engl J Med. 2001;344:68\u20139.","journal-title":"N Engl J Med"},{"key":"1187_CR9","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/590968","volume":"47","author":"T Umemura","year":"2008","unstructured":"Umemura T, Tanaka E, Kiyosawa K. Kumada H; Japan de novo Hepatitis B Research Group. Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan. Clin Infect Dis. 2008;47:e52\u20136.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"1187_CR10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/cid\/civ344","volume":"61","author":"S Kusumoto","year":"2015","unstructured":"Kusumoto S, Tanaka Y, Suzuki R, et al. Monitoring of hepatitis B virus (HBV) DNA and risk of HBV REactivation in B-Cell lymphoma: a prospective observational study. Clin Infect Dis. 2015;61(5):719\u201329.","journal-title":"Clin Infect Dis"},{"key":"1187_CR11","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/nm1096-1104","volume":"2","author":"B Rehermann","year":"1996","unstructured":"Rehermann B, Ferarri C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients\u2019 recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med. 1996;2:1104\u20138.","journal-title":"Nat Med"},{"key":"1187_CR12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510270526","volume":"27","author":"H Yotsuyanagi","year":"1998","unstructured":"Yotsuyanagi H, Yasuda K, Iino S, et al. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology. 1998;27:1377\u201382.","journal-title":"Hepatology"},{"key":"1187_CR13","doi-asserted-by":"crossref","first-page":"a021436","DOI":"10.1101\/cshperspect.a021436","volume":"5","author":"CL Lin","year":"2015","unstructured":"Lin CL, Kao JH. HBV Genotypes and Variants. Cold Spring Harbor Perspect. 2015;5:a021436.","journal-title":"Cold Spring Harbor Perspect"},{"key":"1187_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00535-008-2197-2","volume":"43","author":"K Hayashi","year":"2008","unstructured":"Hayashi K, Katano Y, Takeda Y, et al. Association of hepatitis B virus subgenotypes and basal core promoter\/precore region variants with the clinical features of patients with acute hepatitis. J Gastroenterol. 2008;43:558\u201364.","journal-title":"J Gastroenterol"},{"key":"1187_CR15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/jmv.21995","volume":"83","author":"F Sugauchi","year":"2011","unstructured":"Sugauchi F, Tanaka Y, Kusumoto S, et al. Virological and clinical characteristics on reactivation of occult hepatitis B in patients with hematological malignancy. J Med Virol. 2011;83:412\u20138.","journal-title":"J Med Virol"},{"key":"1187_CR16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1872-034X.2012.01105.x","volume":"43","author":"M Oketani","year":"2013","unstructured":"Oketani M, Ido A, Nakayama N, et al. Etiology and prognosis of fulminant hepatitis and late-onset hepatic failure in Japan: summary of the annual nationwide survey between 2004 and 2009. Hepatol Res. 2013;43:97\u2013105.","journal-title":"Hepatol Res."},{"key":"1187_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-2008-1063926","volume":"1","author":"RP Perrillo","year":"1981","unstructured":"Perrillo RP, Aach RD. The clinical course and chronic sequelae of hepatitis B virus infection. Semin Liver Dis. 1981;1:15\u201325.","journal-title":"Semin Liver Dis"},{"key":"1187_CR18","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JCM.00726-13","volume":"51","author":"N Shinkai","year":"2013","unstructured":"Shinkai N, Matsuura K, Sugauchi F, et al. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance. J Clin Microbiol. 2013;51:3484\u201391.","journal-title":"J Clin Microbiol"},{"key":"1187_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1099\/vir.0.19633-0","volume":"85","author":"TT Huy","year":"2004","unstructured":"Huy TT, Ushijima H, Quang VX, et al. Genotype C of hepatitis B virus can be classified into at least two subgroups. J Gen Virol. 2004;85:283\u201392.","journal-title":"J Gen Virol"},{"issue":"4","key":"1187_CR20","first-page":"406","volume":"4","author":"N Saitou","year":"1987","unstructured":"Saitou N, Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987;4(4):406\u201325.","journal-title":"Mol Biol Evol"},{"key":"1187_CR21","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2307\/2408678","volume":"39","author":"J Felsenstein","year":"1985","unstructured":"Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution. 1985;39:783\u201391.","journal-title":"Evolution"},{"key":"1187_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jmv.20516","volume":"78","author":"A Avell\u00f3n","year":"2006","unstructured":"Avell\u00f3n A, Echevarria JM. Frequency of hepatitis B virus \u2018a\u2019 determinant variants in unselected Spanish chronic carriers. J Med Virol. 2006;78:24\u201336.a.","journal-title":"J Med Virol"},{"key":"1187_CR23","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1017\/S0950268815000242","volume":"143","author":"XY Wang","year":"2015","unstructured":"Wang XY, Harrison TJ, He X, et al. The prevalence of mutations in the major hydrophilic region of the surface antigen of hepatitis B virus varies with subgenotype. Epidemiol Infect. 2015;143:3572\u201382.","journal-title":"Epidemiol Infect"},{"key":"1187_CR24","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jmv.20824","volume":"79","author":"K Hayashi","year":"2007","unstructured":"Hayashi K, Katano Y, Takeda Y, et al. Comparison of hepatitis B virus subgenotypes in patients with acute and chronic hepatitis B and absence of lamivudine-resistant strains in acute hepatitis B in Japan. J Med Virol. 2007;79:366\u201373.","journal-title":"J Med Virol"},{"key":"1187_CR25","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/jmv.21309","volume":"80","author":"M Kobayashi","year":"2008","unstructured":"Kobayashi M, Ikeda K, Arase Y, et al. Change of hepatitis B virus genotypes in acute and chronic infections in Japan. J Med Virol. 2008;80:1880\u20134.","journal-title":"J Med Virol"},{"key":"1187_CR26","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s007050050463","volume":"143","author":"K Takahashi","year":"1998","unstructured":"Takahashi K, Akahane Y, Hino K, Ohta Y, Mishiro S. Hepatitis B virus genomic sequence in the circulation of hepatocellular carcinoma patients: comparative analysis of 40 full-length isolates. Arch Virol. 1998;143:2313\u201326.","journal-title":"Arch Virol"},{"key":"1187_CR27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/hep.27604","volume":"61","author":"R Salpini","year":"2015","unstructured":"Salpini R, Colagrossi L, Bellocchi MC, et al. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology. 2015;61:823\u201333.","journal-title":"Hepatology"},{"key":"1187_CR28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000360947","volume":"57","author":"A Kramvis","year":"2014","unstructured":"Kramvis A. Genotypes and genetic variability of hepatitis B virus. Intervirology. 2014;57:141\u201350.","journal-title":"Intervirology"},{"key":"1187_CR29","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","volume":"26","author":"AR Zanetti","year":"2008","unstructured":"Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26:6266\u201373.","journal-title":"Vaccine."},{"key":"1187_CR30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hep.510260336","volume":"26","author":"HY Hsu","year":"1997","unstructured":"Hsu HY, Chang MH, Ni YH, Lin HH, Wang SM, Chen DS. Surface gene mutants of hepatitis B virus in infants who develop acute or chronic infections despite immunoprophylaxis. Hepatology. 1997;26:786\u201391.","journal-title":"Hepatology"},{"key":"1187_CR31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000252780","volume":"53","author":"NH Park","year":"2010","unstructured":"Park NH, Chung YH, Lee HS. Impacts of vaccination on hepatitis B viral infections in Korea over a 25-year period. Intervirology. 2010;53:20\u20138.","journal-title":"Intervirology"},{"key":"1187_CR32","doi-asserted-by":"crossref","first-page":"6214","DOI":"10.3748\/wjg.v19.i37.6214","volume":"19","author":"A Elkady","year":"2013","unstructured":"Elkady A, Aboulfotuh S, Ali EM, et al. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. World J Gastroenterol. 2013;19:6214\u201320.","journal-title":"World J Gastroenterol"},{"key":"1187_CR33","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJM199106133242404","volume":"324","author":"M Omata","year":"1991","unstructured":"Omata M, Ehata T, Yokosuka O, Hosoda K, Ohto M. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med. 1991;324:1699\u2013704.","journal-title":"N Engl J Med"},{"key":"1187_CR34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1872-034X.2012.00998.x","volume":"42","author":"M Oketani","year":"2012","unstructured":"Oketani M, Ido A, Uto H, Tsubouchi H. Prevention of hepatitis B virus reactivation in patients receiving immunosuppressive therapy or chemotherapy. Hepatol Res. 2012;42:627\u201336.","journal-title":"Hepatol Res."}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1187-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-016-1187-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1187-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-016-1187-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T16:44:17Z","timestamp":1600274657000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-016-1187-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,4]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["1187"],"URL":"https:\/\/doi.org\/10.1007\/s00535-016-1187-z","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"type":"print","value":"0944-1174"},{"type":"electronic","value":"1435-5922"}],"subject":[],"published":{"date-parts":[[2016,3,4]]}}}